Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
erenumab | calcitonin gene-related peptide receptor | NA | Successful target | TTD , DGIDB | Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperprolactinemia[MeSHID:D006966] |
12.73 | approved | antagonist |
erenumab | calcitonin gene-related peptide receptor | NA | Successful target | TTD , DGIDB | Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperprolactinemia[MeSHID:D006966] |
12.73 | approved | unknown |
erenumab | calcitonin gene-related peptide type 1 receptor | biotech | NA | drugbank , DGIDB | Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperprolactinemia[MeSHID:D006966] |
12.73 | approved,investigational | antagonist |
erenumab | calcitonin gene-related peptide type 1 receptor | biotech | NA | drugbank , DGIDB | Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperprolactinemia[MeSHID:D006966] |
12.73 | approved,investigational | unknown |
click here to return to the previous page |